HEMORRHAGIC SHOCK TREATMENT MARKET ANALYSIS

Hemorrhagic Shock Treatment Market, By Drug Type ( NVX-408, YW-356, LB-1148, Neutrolide, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Channels ) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI4097
Pages :280
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Hemorrhagic Shock Treatment Market - Key Players

Major players operating in the global hemorrhagic shock treatment market include Biomedica Management Corporation, NuvOxPharma LLC, Leading BioSciences, Inc, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Johnson & Johnson Services Inc, AstraZeneca, Daiichi Sankyo Company, Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, ZydusCadila, Amneal Pharmaceuticals LLC.